Company · CIK 1595585
Tricida, Inc.
| CIK | 1595585 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-08-10 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-264835 | 2022-05-10 | 2023-06-16 | 3 | |
| 333-252359 | 2021-01-22 | 2021-11-15 | 3 | |
| 333-233189 | 2019-08-09 | 2019-08-09 | 1 | |
| 333-230657 | 2019-04-01 | 2019-04-05 | 3 | |
| 333-225420 | 2018-06-04 | 2018-06-29 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-06-16 | EFFECTDeclared effective | 333-264835 | 9999999995-23-001775 |
| 2022-05-19 | EFFECTDeclared effective | 333-264835 | 9999999995-22-001539 |
| 2022-05-10 | S-3Shelf registered | 333-264835 | 0001595585-22-000041 |
| 2021-11-15 | 424B5Shelf takedown | 333-252359 | 0001193125-21-328989 |
| 2021-03-22 | EFFECTDeclared effective | 333-252359 | 9999999995-21-001052 |
| 2021-01-22 | S-3Shelf registered | 333-252359 | 0001628280-21-000729 |
| 2019-08-09 | S-3ASRShelf registered | 333-233189 | 0001595585-19-000168 |
| 2019-04-05 | 424B4Final prospectus | 333-230657 | 0001628280-19-003938 |
| 2019-04-03 | EFFECTDeclared effective | 333-230657 | 9999999995-19-000593 |
| 2019-04-01 | S-1Registration filed | 333-230657 | 0001628280-19-003724 |
| 2019-02-08 | DRSDraft made public | 377-02496 | 0001628279-19-000021 |
| 2018-06-29 | 424B4Final prospectus | 333-225420 | 0001193125-18-209972 |
| 2018-06-27 | EFFECTDeclared effective | 333-225420 | 9999999995-18-001644 |
| 2018-06-27 | S-1/AAmendment | 333-225420 | 0001193125-18-204419 |
| 2018-06-25 | S-1/AAmendment | 333-225420 | 0001193125-18-201288 |
| 2018-06-18 | S-1/AAmendment | 333-225420 | 0001193125-18-195066 |
| 2018-06-04 | S-1Registration filed | 333-225420 | 0001193125-18-183450 |
| 2018-03-01 | DRSDraft made public | 377-01960 | 0000950123-18-002755 |